Growth factor sequestration and enzyme-mediated release from genipin-crosslinked gelatin microspheres

References

• Hankenson KD, Dishowitz M, Gray C, et al. Angiogenesis in bone regeneration. Injury. 2011;42:556–561.10.1016/j.injury.2011.03.035
   PubMed Web of Science ®Google Scholar
• des Rieux A, Ucakar B, Mupendwa BPK, et al. 3D systems delivering VEGF to promote angiogenesis for tissue engineering. J. Controlled Release. 2011;150:272-278.10.1016/j.jconrel.2010.11.028
   PubMed Web of Science ®Google Scholar
• Poldervaart MT, Wang H, van der Stok J, et al. Sustained release of BMP-2 in bioprinted alginate for osteogenicity in mice and rats. PLoS One. 2013;8:e72610. Epub 2013 Aug 27.10.1371/journal.pone.0072610
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Ikada Y, Tabata Y. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed. 2001;12:77–88. Epub 2001 May 04.10.1163/156856201744461
   PubMed Web of Science ®Google Scholar
• Young S, Wong M, Tabata Y, et al. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Controlled Release. 2005;109:256–274.10.1016/j.jconrel.2005.09.023
   PubMed Web of Science ®Google Scholar
• Gombotz WR, Wee SF. Protein release from alginate matrices. Adv Drug Deliv Rev. 2012;64:194–205.10.1016/j.addr.2012.09.007
   Web of Science ®Google Scholar
• Tabata Y, Nagano A, Ikada Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng.. 1999;5:127–138. Epub 1999 Jun 08.10.1089/ten.1999.5.127
   PubMedGoogle Scholar
• Tabata Y, Nagano A, Muniruzzaman M, et al. In vitro sorption and desorption of basic fibroblast growth factor from biodegradable hydrogels. Biomaterials. 1998;19:1781–1789. Epub 1998 Dec 18.10.1016/S0142-9612(98)00089-1
   PubMed Web of Science ®Google Scholar
• Tabata Y, Gutta S, Langer R. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm Res. 1993;10:487–496. Epub 1993 Apr 01.10.1023/A:1018929531410
   PubMed Web of Science ®Google Scholar
• Kanczler JM, Ginty PJ, Barry JJA, et al. The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation. Biomaterials. 2008;29:1892–1900.10.1016/j.biomaterials.2007.12.031
   PubMed Web of Science ®Google Scholar
• Cohen S, Yoshioka T, Lucarelli M, et al. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res. 1991;08:713–720. Epub 1991 Jun 01.10.1023/A:1015841715384
   Web of Science ®Google Scholar
• Richardson TP, Peters MC, Ennett AB, et al. Polymeric system for dual growth factor delivery. Nat Biotechnol. 2001;19:1029–1034. Epub 2001 Nov 02.10.1038/nbt1101-1029
   PubMed Web of Science ®Google Scholar
• Holland TA, Tabata Y, Mikos AG. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Controlled Release. 2003;91:299–313. Epub 2003 Aug 23.10.1016/S0168-3659(03)00258-X
   PubMed Web of Science ®Google Scholar
• Iwanaga K, Yabuta T, Kakemi M, et al. Usefulness of microspheres composed of gelatin with various cross-linking density. J Microencapsul. 2003;20:767–776. Epub 2003 Nov 05.10.3109/02652040309178087
   PubMed Web of Science ®Google Scholar
• Patel ZS, Yamamoto M, Ueda H, et al. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater. 2008;4:1126–1138. Epub 2008 May 14.10.1016/j.actbio.2008.04.002
   PubMed Web of Science ®Google Scholar
• Nagai N, Kumasaka N, Kawashima T, et al. Preparation and characterization of collagen microspheres for sustained release of VEGF. J Mater Sci Mater Med. 2010;21:1891–1898. Epub 2010 Mar 17.10.1007/s10856-010-4054-0
   PubMed Web of Science ®Google Scholar
• Bigi A, Cojazzi G, Panzavolta S, et al. Stabilization of gelatin films by crosslinking with genipin. Biomaterials. 2002;23:4827–4832. Epub 2002 Oct 04.10.1016/S0142-9612(02)00235-1
   PubMed Web of Science ®Google Scholar
• Huang KS, Lu K, Yeh CS, et al. Microfluidic controlling monodisperse microdroplet for 5-fluorouracil loaded genipin-gelatin microcapsules. J Controlled Release. 2009;137:15–19. Epub 2009 Mar 07.10.1016/j.jconrel.2009.02.019
   PubMed Web of Science ®Google Scholar
• Solorio L, Zwolinski C, Lund AW, et al. Gelatin microspheres crosslinked with genipin for local delivery of growth factors. J Tissue Eng Regen Med. 2010;4:514–523. Epub 2010 Sep 28.10.1002/term.v4:7
   PubMed Web of Science ®Google Scholar
• Yao C-H, Liu B-S, Chang C-J, et al. Preparation of networks of gelatin and genipin as degradable biomaterials. Mater Chem Phys. 2004;83:204–208.10.1016/j.matchemphys.2003.08.027
   Web of Science ®Google Scholar
• Kim S, Kang Y, Krueger CA, et al. Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation. Acta Biomater. 2012;8:1768–1777. Epub 2012 Feb 02.10.1016/j.actbio.2012.01.009
   PubMed Web of Science ®Google Scholar
• Nguyen AH, McKinney J, Miller T, et al. Gelatin methacrylate microspheres for controlled growth factor release. Acta Biomater. 2015;13:101–110.10.1016/j.actbio.2014.11.028
   PubMed Web of Science ®Google Scholar
• Holland TA, Bodde EW, Cuijpers VM, et al. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis and Cartilage. 2007;15:187–197. Epub 2006 Sep 13.10.1016/j.joca.2006.07.006
   PubMed Web of Science ®Google Scholar
• Chang CJ. Effects of nerve growth factor from genipin-crosslinked gelatin in polycaprolactone conduit on peripheral nerve regeneration- In vitro and in vivo. J Biomed Mater Res Part A. 2009;91A:586–596. Epub 2008 Nov 06.10.1002/jbm.a.v91a:2
   Web of Science ®Google Scholar
• Kempen DHR, Lu L, Heijink A, et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials. 2009;30:2816–2825.10.1016/j.biomaterials.2009.01.031
   PubMed Web of Science ®Google Scholar
• Lin Z, Wang J-S, Lin L, et al. Effects of BMP2 and VEGF165 on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. Exp Ther Med. 2014;7:625–629.
   PubMed Web of Science ®Google Scholar
• Peng H, Usas A, Olshanski A, et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res. 2005;20:2017–2027. Epub 2005 Oct 20.10.1359/JBMR.050708
   PubMed Web of Science ®Google Scholar
• Thomas KA. Vascular Endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem. 1996;271:603–606.10.1074/jbc.271.2.603
   PubMed Web of Science ®Google Scholar
• Unemori EN, Ferrara N, Bauer EA, et al. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol. 1992;153:557–562.10.1002/(ISSN)1097-4652
   PubMed Web of Science ®Google Scholar
• Tsuji K, Bandyopadhyay A, Harfe BD, et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet. 2006;38:1424–1429. Epub 2006 Nov 14.10.1038/ng1916
   PubMed Web of Science ®Google Scholar
• Balseiro S, Nottmeier EW. Vertebral osteolysis originating from subchondral cyst end plate defects in transforaminal lumbar interbody fusion using rhBMP-2. Report of two cases. Spine J. 2010;10:e6–e10.10.1016/j.spinee.2010.04.013
   PubMedGoogle Scholar
• Lewandrowski K-U, Nanson C, Calderon R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: A report of five cases. Spine J. 2007;7:609–614.10.1016/j.spinee.2007.01.011
   PubMed Web of Science ®Google Scholar
• Wong DA, Kumar A, Jatana S, et al. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J. 2008;8:1011–1018.10.1016/j.spinee.2007.06.014
   PubMed Web of Science ®Google Scholar
• Butler MF, Ng Y-F, Pudney PDA. Mechanism and kinetics of the crosslinking reaction between biopolymers containing primary amine groups and genipin. J Polym Sci, Part A: Polym Chem. 2003;41:3941–3953.10.1002/(ISSN)1099-0518
   Web of Science ®Google Scholar
• Lai JY, Li YT, Wang TP. In vitro response of retinal pigment epithelial cells exposed to chitosan materials prepared with different cross-linkers. Int J Mol Sci. 2010;11:5256–5272. Epub 2010 Jan 01.10.3390/ijms11125256
   PubMed Web of Science ®Google Scholar
• Mi F-L, Shyu S-S, Peng C-K. Characterization of ring-opening polymerization of genipin and pH-dependent cross-linking reactions between chitosan and genipin. J Polym Sci, Part A: Polym Chem. 2005;43:1985–2000.10.1002/(ISSN)1099-0518
   Web of Science ®Google Scholar
• Sundararaghavan HG, Monteiro GA, Lapin NA, et al. Genipin-induced changes in collagen gels: Correlation of mechanical properties to fluorescence. J Biomed Mater Res Part A. 2008;87A:308–320. Epub 2008 Jan 09.10.1002/jbm.a.v87a:2
   Web of Science ®Google Scholar
• Wang L, Wang Y, Qu J, et al. The cytocompatibility of genipin-crosslinked silk fibroin films. J Biomater Nanobiotechnol. 2013;04:213–221.10.4236/jbnb.2013.43026
   Google Scholar
• Sung HW, Huang RN, Huang LL, et al. In vitro evaluation of cytotoxicity of a naturally occurring cross-linking reagent for biological tissue fixation. J Biomater Sci Polym Ed. 1999;10:63–78. Epub 1999 Mar 26.10.1163/156856299X00289
   PubMed Web of Science ®Google Scholar
• Qiu J, Li J, Wang G, et al. In vitro investigation on the biodegradability and biocompatibility of genipin cross-linked porcine acellular dermal matrix with intrinsic fluorescence. ACS Appl Mater Interfaces. 2013;5:344–350.10.1021/am302272 k
   PubMed Web of Science ®Google Scholar
• Mu C, Zhang K, Lin W, et al. Ring-opening polymerization of genipin and its long-range crosslinking effect on collagen hydrogel. J Biomed Mater Res Part A. 2013;101A:385–393. Epub 2012 Aug 01.10.1002/jbm.a.v101a.2
   Google Scholar
• Kirchmajer DM, Watson CA, Ranson M, et al. Panhuis Mih. Gelapin, a degradable genipin cross-linked gelatin hydrogel. RSC Adv. 2013;3:1073–1081.
   Web of Science ®Google Scholar
• Lien S-M, Li W-T, Huang T-J. Genipin-crosslinked gelatin scaffolds for articular cartilage tissue engineering with a novel crosslinking method. Mater Sci Eng C. 2008;28:36–43.10.1016/j.msec.2006.12.015
   Web of Science ®Google Scholar
• Lau TT, Wang C, Wang D-A. Cell delivery with genipin crosslinked gelatin microspheres in hydrogel/microcarrier composite. Compos Sci Technol. 2010;70:1909–1914.10.1016/j.compscitech.2010.05.015
   Web of Science ®Google Scholar
• Liang HC, Chang WH, Lin KJ, et al. Genipin-crosslinked gelatin microspheres as a drug carrier for intramuscular administration:In vitro andin vivo studies. J Biomed Mater Res. 2003;65A:271–282. Epub 2003 May 08.10.1002/(ISSN)1097-4636
   Web of Science ®Google Scholar
• Wang A, Cui Y, Li J, et al. Fabrication of gelatin microgels by a “cast” strategy for controlled drug release. Adv Func Mater. 2012;22:2673–2681.10.1002/adfm.v22.13
   Web of Science ®Google Scholar
• Mi F-L, Sung H-W, Shyu S-S. Synthesis and characterization of a novel chitosan-based network prepared using naturally occurring crosslinker. J Polym Sci, Part A: Polym Chem. 2000;38:2804–2814.10.1002/(ISSN)1099-0518
   Web of Science ®Google Scholar
• Chen Q, Jin M, Yang F, et al. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm.. 2013;2013:928315. Epub 2013 Jul 11.
   PubMed Web of Science ®Google Scholar
• Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9:267–285. Epub 2005 Jun 21.10.1111/jcmm.2005.9.issue-2
   PubMed Web of Science ®Google Scholar
• Fonseca KB, Granja PL, Barrias CC. Engineering proteolytically-degradable artificial extracellular matrices. Prog Polym Sci. 2014;39:2010–2029.10.1016/j.progpolymsci.2014.07.003
   Web of Science ®Google Scholar
• Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161–174. Epub 2002 May 07.10.1038/nrc745
   PubMed Web of Science ®Google Scholar
• Ghajar CM, George SC, Putnam AJ. Matrix metalloproteinase control of capillary morphogenesis. Crit Rev Eukaryot Gene Expr. 2008;18:251–278. Epub 2008 Jun 11.10.1615/CritRevEukarGeneExpr.v18.i3
   PubMed Web of Science ®Google Scholar
• Ohkawara B, Iemura S, ten Dijke P, et al. Action range of BMP is defined by its N-terminal basic amino acid core. Curr Biol. 2002;12:205–209. Epub 2002 Feb 13.10.1016/S0960-9822(01)00684-4
   PubMed Web of Science ®Google Scholar
• Yao C, Roderfeld M, Rath T, et al. The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices. Biomaterials. 2006;27:1608–1616.10.1016/j.biomaterials.2005.08.037
   PubMed Web of Science ®Google Scholar
• Cittadini A, Monti MG, Petrillo V, et al. Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure. Eur J Heart Fail. 2011;13:1264–1274. Epub 2011 Nov 03.10.1093/eurjhf/hfr143
   PubMed Web of Science ®Google Scholar
• Chen RR, Silva EA, Yuen WW, et al. Spatio–temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res. 2007;24:258–264.10.1007/s11095-006-9173-4
   PubMed Web of Science ®Google Scholar